Coherus BioSciences Inc
CHRSLatest QuantConomy context for CHRS: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Coherus BioSciences Inc
QuantConomy has a structured record for CHRS. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- CHRS
- Name
- Coherus BioSciences Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq
Recent signals for CHRS
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings earnings release | neutral | 40 | Jan 13, 12:00 AM | CHRS filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-13. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings earnings release | neutral | 40 | Mar 9, 12:00 AM | CHRS filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-03-09. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings earnings release | neutral | 40 | May 11, 12:00 AM | CHRS filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-11. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| CHRS | NASDAQ | fmp | Coherus Oncology, Inc. |
| CHRS | NASDAQ | alphavantage | Coherus Biosciences Inc |
| CHRS | NASDAQ | alpaca | Coherus BioSciences, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Satvat Ali J. | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Newton Charles W. | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Ryan Michael Lee | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Karachun Rita A | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Newcomer Lee Nisley | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | Wahlstrom Mats | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| Jun 5, 2026 | O'Donnell-Tormey Jill | Director | grant | 30,000 | $0.00 | $0 | 4 on EDGAR |
| May 29, 2026 | Lanfear Dennis M | President & CEO | other | 200,000 | — | — | 4 on EDGAR |
| May 29, 2026 | McMichael Bryan J | Chief Financial Officer | other | 100,000 | — | — | 4 on EDGAR |
| Jan 23, 2026 | Lanfear Dennis M | President & CEO | grant | 375,000 | $0.00 | $0 | 4 on EDGAR |
| Jan 22, 2026 | McMichael Bryan J | Chief Financial Officer | grant | 112,500 | $0.00 | $0 | 4 on EDGAR |
| Jan 20, 2026 | Lanfear Dennis M | President & CEO | other | 11,839 | $1.55 | $18,350 | 4 on EDGAR |
| Jan 20, 2026 | McMichael Bryan J | Chief Financial Officer | other | 1,715 | $1.55 | $2,658 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query CHRS context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access